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We report a case of disseminated microsporidiosis 
in a patient with multiple myeloma who had received 
an allogeneic stem cell transplant requiring substantial 
immunosuppression. The causative organism was identiﬁ  ed 
as Tubulinosema acridophagus, conﬁ   rming this genus of 
microsporidia as a novel human pathogen.
M
icrosporidia fungi are human pathogens known 
for causing diarrheal illness in persons infected 
with HIV; however, there is growing awareness of their 
involvement in other cases of host immunosuppression. 
A case of Tubulinosema sp. microsporidian myositis was 
recently reported in a patient with chronic lymphocytic 
leukemia (1). We describe a second case of disseminated 
microsporidiosis caused by a Tubulinosema  sp. in an 
immunosuppressed patient who received an allogeneic 
stem cell transplant for multiple myeloma.
Case Report
The patient was a 33-year-old woman with multiple 
myeloma. After receiving an autologous stem cell 
transplant (SCT), she experienced a relapse of disease 
and was enrolled in an experimental protocol of 
immunoablative chemotherapy, followed by hematopoietic 
SCT at the National Institutes of Health Clinical Center in 
Bethesda, Maryland (www.ClinicalTrials.gov identiﬁ  er 
NCT00520130). Patients in this study are given a 
conditioning regimen of chemotherapy drugs (including 
ﬂ   udarabine and cyclophosphamide), followed by 
prophylaxis against graft-versus-host disease (alemtuzumab 
and cyclosporine).
The patient received a 7/8 HLA-matched allogeneic 
peripheral blood SCT (with a single mismatch at the 
DRB1 locus) from an unrelated donor. Her clinical course 
was complicated by vancomycin-resistant Enterococcus 
faecium bacteremia, meningitis, and concomitant 
noncommunicating hydrocephalus and retinal hemorrhages. 
The bone marrow did not reconstitute, and 35 days after 
the initial transplant, the patient received a second SCT 
from the same donor after a conditioning regimen with 
antithymocyte globulin. Engraftment took place on day 
49, 14 days after the second transplant. Progressive 
respiratory failure and pulmonary inﬁ  ltrates had developed 
over the preceding week despite administration of broad-
spectrum antimicrobial drugs. Results of a bronchoscopy 
on day 49 showed diffuse alveolar hemorrhage and did not 
identify a pathogen. Treatment with activated factor 7 and 
corticosteroids was given with some clinical improvement 
as well as improvement shown on chest radiograph.
A second bronchoalveolar lavage (BAL), performed 
on day 64, again showed diffuse alveolar hemorrhage 
and absence of pathogens. The patient received a second 
course of corticosteroids and activated factor 7. On day 
77, an ophthalmologic examination was performed during 
a routine follow-up, and new retinal lesions suggestive of 
candida chorioretinitis were seen. Liposomal amphotericin 
B was substituted for prophylactic anidulafungin, and an 
intravitreal injection of amphotericin B was given for a 
subfoveal lesion.
At this time, the patient also had increasing 
hyperbilirubinemia and elevation of liver aminotransferases, 
together with diarrhea, abdominal distension, and new 
ascites. Graft-versus-host disease of the gut and liver was 
suspected. A colonoscopy on day 79 showed that, with the 
exception of 1 ulcer, the colonic mucosa appeared normal; 
biopsy samples showed nonspeciﬁ  c inﬂ  ammation and a 
few apoptotic bodies. A liver biopsy and paracentesis were 
performed on day 85. Samples were stained with calcoﬂ  uor 
white, which revealed yeast-like organisms 2–3 μm in 
diameter (Figure 1, panel A; online Appendix Figure, 
panels A and B, wwwnc.cdc.gov/EID/article/18/6/12-
0047-FA1.htm). The samples were also cultured for the 
presence of fungi, but results were negative.
Over the next 10 days, despite treatment with broad-
spectrum antimicrobial drugs and corticosteroids, the 
patient had intermittent fever, continued elevation of liver 
enzymes, and progressive respiratory insufﬁ  ciency  with 
episodes of diffuse alveolar hemorrhage. Examination of 
BAL samples on days 90, 92, 96, and 97 was unrevealing. 
On day 96, multiple discrete, nonblanchable red macules 
and papules developed on the patient’s face, arms, legs, and 
trunk; the macules and papules were initially suggestive of 
disseminated candidiasis. Skin biopsy showed cysts mostly 
within the epidermis and follicular epithelium, similar to 
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ascitic ﬂ  uid; these cysts featured closely packed, uniform, 
oval basophilic structures (Figure 1, panels B and C).
On day 96, diffuse alveolar hemorrhage recurred. BAL 
was performed, and staining with Diff-Quik (Siemens 
Healthcare Diagnostics Inc., Deerﬁ   eld, IL, USA) and 
modiﬁ  ed trichrome showed that the ﬂ  uid samples were now 
positive for intracellular yeast-like forms. In retrospect, 
we determined that the BAL samples from day 90 also 
contained yeast-like forms, but they could not be identiﬁ  ed 
at that time (Figure 1, panel D). Refractory hypoxemia 
developed, and the patient died on day 97 after the initial 
transplant. No postmortem examination was performed.
The remaining clinical specimens were subsequently 
examined to determine if the yeast-like forms were 
microsporidia. Warthin-Starry staining showed that all 
organisms in the skin and ascitic ﬂ  uid were consistent with 
microsporidia (Figure 1, panel C; online Appendix Figure, 
panel C). Similar organisms were identiﬁ  ed in the BAL 
samples from days 90 and 96; spore size averaged 3.5 μm 
(range 3.3–3.9 μm) (Figure 1, panel D). Results of calcoﬂ  uor 
white and modiﬁ  ed acid-fast staining of the organisms were 
also positive, consistent with microsporidia.
Electron micrographs of skin and peritoneal ﬂ  uid 
revealed microsporidian spores with features that were 
compatible with the genus Tubulinosema. Spores had a 
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Figure 1. Microsporidium detected in clinical 
specimens from a stem cell transplant 
patient who had undergone substantial 
immunosuppression. A) Calcoﬂ  uor  white–
stained ascitic ﬂ   uid (original magniﬁ  cation 
×500). B) Hematoxylin and eosin–stained 
skin biopsy sample (original magniﬁ  cation 
×400). The arrow indicates clusters of 
spores. C) Warthin-Starry–stained skin 
biopsy sample (original magniﬁ  cation ×400). 
The arrows indicate clusters of spores. D) 
Modiﬁ   ed trichrome–stained material from 
bronchoalveolar lavage. Scare bar = 5.0 
μm. E) Transmission electron micrograph 
depicting 1 of the microsporidian spores 
identiﬁ  ed in a skin biopsy sample. The image 
shows the polar ﬁ  lament (PF), containing 13 
to 14 coils, in a single layer with anisoﬁ  lar 
arrangement (An); the plasma membrane 
(PM); the exospore (Ex); the endospore (En); 
and polyribosomes (P). Scale bar = 1 μm.Microsporidiosis in Immunosuppressed Patient
single layer of polar tubule or ﬁ  lament with 11–14 coils; 
the last 3 coils were clearly smaller in some spores (i.e., 
they had an anisoﬁ  lar polar tubular arrangement) (Figure 
1, panel E). The quality of the electron micrograph was 
limiting and did not allow visualization of the diplokaryon 
nucleus.
BAL samples were sent to the reference diagnostic 
laboratory for parasitology at the Centers for Disease Control 
and Prevention for molecular analysis. A nested PCR 
approach was applied, using the outer primers microFN18 
(5′-CACCAGGTTGATTCTGCC-3′) and microR9 (5′-
GTATGATCCTGCCACAGATTCTTCTAT-3′) and the 
inner primers Ta50f (5′-GGTTGATTCTGCCTGTT
ATATGT-3′) and Ta1300r (5′-GGACACATTCATC
GTAACTTAGT-3′). Phylogenetic analysis of the resulting 
1,246-bp sequence (GenBank accession no. JQ247017) 
revealed a high similarity to the small subunit ribosomal 
RNA gene from T. acridophagus (Figure 2), with only 1 
nucleotide difference between the 2 sequences. Our ﬁ  nal 
clinical diagnosis was disseminated T. acridophagus 
microsporidiosis with skin, liver, peritoneal, lung, and 
possibly chorioretinal involvement. Histopathology was 
notable for a paucity of inﬂ  ammation around the organisms.
Conclusions
Along with another case of Tubulinosema sp. 
microsporidiosis (1), this case of disseminated 
microsporidiosis in an immunosuppressed SCT patient 
solidiﬁ  es  Tubulinosema sp. as a novel pathogen in 
immunosuppressed persons. By using molecular analysis, 
we characterized the microsporidian from the patient in our 
study to the species level (T. acridophagus).
Of 3 other reported cases of pulmonary micro-
sporidiosis after SCT, 2 were in T cell–depleted patients 
(2,3), and the third was in a patient receiving high-dose 
methylprednisolone (1 g/m2) to treat graft-versus-host 
disease (4). The patient in our study was substantially 
immunosuppressed. She received alemtuzumab with 
her  ﬁ   rst allogeneic transplant and conditioning with 
antithymocyte globulin before her second transplant, 
resulting in signiﬁ  cant in vivo T-cell depletion; she was 
also receiving adrenal corticosteroids. Because the patient 
had retinal changes suggestive of candidemia, we initially 
suspected that she had a disseminated infection. Although 
we did not identify the cause of these retinal changes, a 
case of endopthalmitis caused by microsporidia has been 
reported (5).
Microsporidia have only rarely been reported in the 
skin (6–8). The organisms we found in the skin and liver 
of the patient in our study were similar, providing the clue 
to the eventual postmortem diagnosis of disseminated 
microsporidiosis. This report reinforces the need to 
consider microsporidiosis as a life-threatening condition 
and a potential cause of diffuse alveolar hemorrhage after 
SCT (2,3), particularly in patients with extreme T-cell 
dysfunction.
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